Company / Free Cash Flow per Share
Regeneron Pharmaceuticals Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
$35.89
FY2025
5-year range
$17.41 / $35.89
FY2021-FY2025
Trend
+11.2%
vs FY2024
Sector context
#2 of 192
Health Care
What the data says
Among 192 Health Care companies, Regeneron Pharmaceuticals is in the top 1% for free cash flow per share. Free Cash Flow per Share has fluctuated over the past 10 years, ranging from $8.59 in FY2016 to $35.89 in FY2025.
Based on SEC 10-K filings.
35.89 in FY2025 with a 5-year CAGR of +17.9%. Ranks 2nd among 192 companies in Health Care.
Improved from $34.54 to $35.89 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- +27.3%
- 5-Year CAGR
- +17.9%
- 10-Year CAGR
- -
Sector benchmark
+280.9% above sector average
Key checks
Key Insights
- In FY2025, free cash flow per share increased 11.2% year-over-year.
- Ranks #2 out of 192 companies in the Health Care sector.
- Lowest free cash flow per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 3.03 (safe zone, above 2.9 threshold)
- Strong profit margin: 32.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $35.89 | +11.2% |
| FY2024 | $32.29 | -6.5% |
| FY2023 | $34.54 | +98.4% |
| FY2022 | $17.41 | -0.3% |
| FY2021 | $17.46 | +10.6% |
| FY2020 | $15.78 | -8.6% |
| FY2019 | $17.26 | +10.8% |
| FY2018 | $15.58 | +73.5% |
| FY2017 | $8.98 | +4.5% |
| FY2016 | $8.59 | +46.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026